Document is current

Article History

Received: 3 August 2023

Accepted: 15 April 2024

First Online: 15 May 2024

Declarations

:

: This study employed survey and interview methodologies as its primary research methods. The vulnerable demographic in this research comprised the older population. The research procedures ensured that the patients would not face any additional risks. They only need to receive ADL assessment on time as required. Patients may withdraw from the study at any stage of the study. The research procedures ensured that the participants would not face additional risks, although they were obligated to undergo scheduled ADL assessments. Any alterations to the research protocol emerging during the study were expeditiously communicated to the ethics committee and implemented solely upon receiving approval. Throughout the research process, participants (including patients with stroke, health professionals, and caregivers) were incorporated into the study only after endorsing a hard copy of the informed consent form, signifying their comprehension of the principal objectives and fundamental procedures of this investigation.This study was approved by the Ethics Committee of the Second People’s Hospital of Shenzhen (ethics approval number: 20210812003-FS01) and registered in Clinical Trials on January 31, 2022 (No.: NCT05214638). All inpatients and their proxies were invited to participate in the study after providing informed consent. All authors confirm that all the methods were performed in accordance with the relevant guidelines and regulations.

: Not applicable.

: The authors declare no competing interests.